Pharmaids Pharmaceuticals Limited

PHARMAID

INE117D01018

Pharmaceuticals

Delayed Bombay S.E. Other stock markets 10:00:09 11/06/2024 am IST			5-day change	1st Jan Change
55.55 ^INR	+3.31%		+3.60%	+14.11%

28/05	Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
28/05	Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI

Pharmaids Pharmaceuticals Limited completed the acquisition of 99.86% stake in Adita Bio Sys Private Ltd.

March 02, 2024

Pharmaids Pharmaceuticals Limited (BSE:524572) agreed to acquire 99.86% stake in Adita Bio Sys Private Ltd. for INR 530 million on January 6, 2024. The deal has been approved by board of directors of Pharmaids Pharmaceuticals Limited. As of March 31, 2023, Adita Bio Sys reported net worth of INR 14.2 million, and turnover of INR 45.2 million.

Pharmaids Pharmaceuticals Limited (BSE:524572) completed the acquisition of 99.86% stake in Adita Bio Sys Private Ltd. on March 2, 2024.

Latest news about Pharmaids Pharmaceuticals Limited

Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	28/05	CI
Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	28/05	CI
Pharmaids Pharma Completes Acquisition of Adita Bio Sys	04/03	MT
Pharmaids Pharmaceuticals Limited completed the acquisition of 99.86% stake in Adita Bio Sys Private Ltd.	02/03	CI
Pharmaids Pharmaceuticals Limited announced that it has received INR 525.448343 million in funding from Asian Hotels Limited, Tumkur Trade Center Private Limited and another investors	02/03	CI
Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02	CI
Pharmaids Pharmaceuticals Names Chairman; Shares Slip 5%	12/02	MT
Pharmaids Pharmaceuticals Buys Additional 1.25% Stake in Anugraha Chemicals	09/02	MT
Pharmaids Pharmaceuticals Limited Appoints Shankarappa Nagaraja Vinaya Babu as Non-Executive Non-Independent Director and Chairman	31/01	CI
Pharmaids Pharmaceuticals Limited agreed to acquire 99.86% stake in Adita Bio Sys Private Ltd. for INR 530 million.	07/01	CI
Pharmaids Pharmaceuticals Limited Approves the Appointment of Dr. Prasad S as Chief Executive Officer	07/01	CI
Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11/11	CI
Pharmaids Pharmaceuticals Limited Announces Board Changes	29/23/29	CI
Pharmaids Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	04/23/04	CI
Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	29/23/29	CI
Pharmaids Pharmaceuticals Limited Announces Change in Registered Office Address	23/23/23	CI
Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	13/23/13	CI
Pharmaids Pharmaceuticals to Acquire Majority Stake in Anugraha Chemicals	26/23/26	MT
Pharmaids Pharmaceuticals Limited Announces Vyasmurti Madhavrao Shingatgeri Resigned from the Post of Independent Director of the Company	23/23/23	CI
Pharmaids Pharmaceuticals Approves Appointment of Pattamadai Natarajasarma Vijay as an Independent Director	03/23/03	CI
Pharmaids Pharmaceuticals to Raise $2 Million via Equity Offering; Shares Jump 7%	29/22/29	MT
Pharmaids Pharmaceuticals Limited Approves Resignation of Veerareddy Vallapureddy as Independent Director	29/22/29	CI
Pharmaids Pharmaceuticals Limited announced that it expects to receive INR 168 million in funding	29/22/29	CI
Pharmaids Pharmaceuticals Swings to Loss in Fiscal Q2	23/22/23	MT
Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	09/22/09	CI

Chart Pharmaids Pharmaceuticals Limited

Duration

Period

More charts

Company Profile

Pharmaids Pharmaceuticals Limited is an India-based suppliers of a range of specialty chemicals, skin care, hospital care and generic products in the areas of orthopedic, neuro and gastro, and other. The Company is engaged in the business of trading and manufacturing of generics, bulk drugs and intermediaries, and other. The Company operates through a single segment, Drug Formulations. Its specialty chemicals products include Retino!, DL Alpha Tocopherol, D Pantothenate, Cyanocobalamin, Pyridoxine Hcl, Thiamine, Nicotinic Acid, Water Sol. Vitamin E, Coenzyme Q10 and D-Biotin. Its skin care products include Best care hands, Hands Sanitizer, Moisturizing Cream, Skinsure Plus, SkinSure Ultra, Alcohol Gel and Barrier Cream. Its hospital care products include Xepi Rub M, Facein Spray, Sod Hypochlorite, Sanmedin, Strumen G, Strumen TRIACID, Facein Eco, Facein Power 256, Facein Spray, Sod Hypochlorite, Wipes and PPE. Its generic products include Linzomust, Benfoshine, Amplimmune and other.

Sector

Pharmaceuticals

Calendar

14/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
PHARMAIDS PHARMACEUTICALS LIMITED	+14.11%	22.7M
ELI LILLY AND COMPANY	+48.39%	779B
JOHNSON & JOHNSON	-6.13%	354B
MERCK & CO., INC.	+20.61%	333B
ABBVIE INC.	+10.00%	301B
ASTRAZENECA PLC	+18.87%	249B
ROCHE HOLDING AG	-1.96%	216B
NOVARTIS AG	+11.11%	214B
AMGEN INC.	+5.80%	163B
PFIZER, INC.	-2.50%	159B